Marks’ resignation leaves the field without a regulator many view as “integral” to its progress over the last decade.
Industry updates and investment insights—including investor behavior and fundraising advice—were among the topics experts ...
The arc of biotechnology is one of breakthroughs and struggles, writes Tim Hunt, CEO of the Alliance for Regenerative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback